Related Experiment Video

Updated: Jul 31, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.0K

Infective endocarditis at a tertiary-care hospital in China

Lulu Ma1, Ying Ge2, Haobo Ma3

  • 1Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.

Journal of Cardiothoracic Surgery
|June 12, 2020
PubMed

Insights

Infective endocarditis in China primarily affects younger males, with Viridans Group Streptococci as the main cause. Older age, heart failure, and stroke increase in-hospital mortality risk.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Clinical Medicine

Background:

  • Infective endocarditis (IE) is a serious infection affecting heart valves.
  • Understanding clinical features and mortality risk factors is crucial for patient outcomes.
  • Data from China provides unique insights into IE epidemiology and management.

Purpose of the Study:

  • To delineate the clinical characteristics of infective endocarditis in a Chinese general hospital.
  • To identify significant risk factors contributing to in-hospital mortality from IE.
  • To analyze the epidemiological trends and etiological agents of IE in the region.

Main Methods:

  • Retrospective study including 381 patients diagnosed with definite or possible IE.
  • Inclusion criteria based on modified Duke criteria from January 2013 to June 2018.
  • Analysis of patient demographics, causative pathogens, valve involvement, treatment, and mortality.

Main Results:

  • The study included 381 patients (mean age 46 years, 66.9% male).
  • Community-acquired IE was most common, with Viridans Group Streptococci (37.5%) as the leading pathogen.
  • In-hospital mortality was 8.4%, with risk factors including age >70, heart failure, stroke, and medical therapy.

Conclusions:

  • Infective endocarditis in China presents with younger patients and a lower mortality rate compared to some Western studies.
  • Viridans Group Streptococci remain the predominant causative agent.
  • Advanced age, heart failure, stroke, and non-surgical management are key predictors of in-hospital mortality.
Abstract

Keywords:
In-hospital mortalityInfective endocarditisViridans group streptococci

More Related Videos

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

767
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

428

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...